CONFERENCE PROCEEDING
Determining the feasibility of a pharmacistdelivered
smoking cessation intervention
for rural smokers in partnership with
independent community pharmacies
More details
Hide details
1
Department of Public Health Sciences, School of Medicine, University of Virginia, Charlottesville, United States
Publication date: 2022-07-05
Tob. Prev. Cessation 2022;8(Supplement):A31
ABSTRACT
Background:
Tobacco use disparities exist despite the widespread dissemination
of evidence-based tobacco cessation interventions. Pharmacists
are under-utilized community resources to address tobacco
control, given their centralized placement in the community,
clinical expertise and frequent patient interactions; however,
pharmacists rarely provide tobacco cessation services to their
customers due to a lack of standardized, reimbursable programs.
Objective:
The goal of this study was to determine the feasibility of delivering
a smoking cessation intervention through independent pharmacies
in rural communities that uses a standard documentation and
billing system for pharmacy reimbursement of services.
Methods:
Twenty-four rural smokers were randomized in a fully crossed
factorial design to: 1) QuitAid, a pharmacist delivered novel
5 session intervention (Yes vs No); 2) Combination nicotine
replacement therapy (NRT) Gum + NRT Patch (vs NRT patch
alone); and/or 3) 8 weeks of NRT (vs standard 4 weeks). The
primary outcomes were the feasibility of the approach, as measured
by feasibility of recruitment, randomization, and retention.
Results:
Participants were recruited within 7 weeks using an ask-adviseconnect
method (66%) at a local independent pharmacy, while
the rest were self-referred from store signage (16%), prescription
bag advertisements (4%) and word of mouth (16%). Over 82%
of the QuitAid sessions were completed, and 83% of participants
were retained at the follow-up at 3 months. Overall, participants
felt that the program was a good fit (Means: 3.69–4.62) and NRT
was useful (Means: 4.38–4.46) on 5-point Likert scales. The
community pharmacists reported that the QuitAid intervention
was straightforward and well received by participants.
Conclusions:
A smoking cessation intervention that utilizes a standard
documentation and billing platform could provide a highly
disseminable avenue for pharmacist-delivered smoking cessation
for hard-to-reach smokers. Because smoking cessation medications
are primarily available through pharmacies, a unique opportunity
exists for pharmacists to become the recognized community
resource for providing smoking cessation medication support.
CITATIONS (1):
1.
Testing the feasibility of the QuitAid smoking cessation intervention in a randomized factorial design in an independent, rural community pharmacy
Melissa A. Little, Taylor Reid, Matthew Moncrief, Wendy Cohn, Kara P. Wiseman, Candace H. Wood, Wen You, Roger T. Anderson, Rebecca A. Krukowski
Pilot and Feasibility Studies